loader
A wholly owned subsidiary and the investment banking arm of State Bank of India
✕
searchiconmb
✕
pharma-healthcare

Pharma & Healthcare

SBICAPS has advised and provided services for varied businesses in the Healthcare segment. This includes biotechnology, diagnostics, life sciences, healthcare services, medical devices, and pharmaceutical businesses.

Select Transactions

ENTERO HEALTHCARE SOLUTIONS LTD.
Value: INR 1,600.00 Cr.
IPO
2024
MEDI ASSIST HEALTHCARE SERVICES LTD.
Value: INR 1,171.58 Cr.
IPO
2024
TELANGANA SUPER-SPECIALTY HOSPITALS CORP. LTD.
Value: USD 475 mn
Financial Advisor and Debt Arranger
2023
Glenmark Life Sciences Limited
Value: INR 1513.6 Crores
IPO
2021
GLENMARK LIFE SCIENCES LTD.
Value: INR 1,513.60 Crores
IPO
2021
WINDLAS BIOTECH LTD.
Value: INR 401.54 Crores
IPO
2021
TARSONS PRODUCTS LTD.
Value: INR 1,023.54 Crores
IPO
2021
Windlas Biotech
Value: INR 401.5 Crores
IPO
2021
LAURUS LABS Limited
Value: INR 1,330.51 Crores
All Equity Capital Market Transaction
2016
Neuland Laboratories Limited
Value: INR 25 Crores
Rights Issue
2014

    Subscribe to content and reports from SBICAPS

    I hereby provide my consent to share my email id with SBICAPS for the purpose of availing the service of subscription to the content and reports from SBICAPS and let them use, share and retain it to provide, analyse, administer, enhance and extend their service.